Mitchell S. Steiner

7.7k total citations
133 papers, 5.9k citations indexed

About

Mitchell S. Steiner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mitchell S. Steiner has authored 133 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Mitchell S. Steiner's work include Prostate Cancer Treatment and Research (55 papers), Prostate Cancer Diagnosis and Treatment (29 papers) and Hormonal and reproductive studies (18 papers). Mitchell S. Steiner is often cited by papers focused on Prostate Cancer Treatment and Research (55 papers), Prostate Cancer Diagnosis and Treatment (29 papers) and Hormonal and reproductive studies (18 papers). Mitchell S. Steiner collaborates with scholars based in United States, Australia and United Kingdom. Mitchell S. Steiner's co-authors include Ronald A. Morton, James T. Dalton, Evelyn Barrack, Patrick C. Walsh, Fray F. Marshall, Michael L. Hancock, Patrick C. Walsh, Sharan Raghow, Stanford M. Goldman and David M. Quinlan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Mitchell S. Steiner

130 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell S. Steiner United States 42 2.9k 1.7k 1.1k 1.1k 1.1k 133 5.9k
J. Brantley Thrasher United States 44 3.2k 1.1× 1.8k 1.0× 966 0.9× 950 0.9× 844 0.8× 134 6.6k
Ronald A. Morton United States 30 1.9k 0.6× 1.7k 1.0× 715 0.7× 520 0.5× 605 0.6× 49 4.0k
Masaru Murai Japan 44 2.7k 0.9× 2.4k 1.4× 1.3k 1.2× 299 0.3× 348 0.3× 234 6.5k
E. David Crawford United States 38 5.1k 1.8× 990 0.6× 1.5k 1.4× 1.6k 1.5× 843 0.8× 133 9.1k
Armen Aprikian Canada 48 4.2k 1.4× 2.2k 1.3× 2.0k 1.9× 946 0.9× 930 0.9× 279 8.7k
Satoru Kawakami Japan 40 2.2k 0.7× 1.5k 0.9× 985 0.9× 471 0.4× 442 0.4× 251 5.1k
Stephen C. Jacobs United States 43 3.2k 1.1× 1.4k 0.8× 907 0.9× 968 0.9× 354 0.3× 130 6.3k
J. Edson Pontes United States 43 3.5k 1.2× 1.4k 0.8× 1.2k 1.2× 444 0.4× 728 0.7× 155 6.0k
Toshiyuki Kamoto Japan 37 1.6k 0.5× 1.4k 0.8× 840 0.8× 386 0.4× 393 0.4× 262 3.9k
Gero Kramer Austria 34 2.9k 1.0× 1.1k 0.6× 1.1k 1.0× 886 0.8× 409 0.4× 185 5.0k

Countries citing papers authored by Mitchell S. Steiner

Since Specialization
Citations

This map shows the geographic impact of Mitchell S. Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell S. Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell S. Steiner more than expected).

Fields of papers citing papers by Mitchell S. Steiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell S. Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell S. Steiner. The network helps show where Mitchell S. Steiner may publish in the future.

Co-authorship network of co-authors of Mitchell S. Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell S. Steiner. A scholar is included among the top collaborators of Mitchell S. Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell S. Steiner. Mitchell S. Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bhasin, Shalender, Venkatesh Krishnan, Thomas W. Storer, Mitchell S. Steiner, & Adrian S. Dobs. (2023). Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease. The Journals of Gerontology Series A. 78(Supplement_1). 25–31. 19 indexed citations
3.
Markowski, Mark C., Ronald Tutrone, Christopher Pieczonka, et al.. (2022). A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent. Clinical Cancer Research. 28(13). 2789–2795. 28 indexed citations
4.
Zappala, Stephen, Yan Dong, Vincent Linder, et al.. (2017). The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information. International Journal of Clinical Practice. 71(6). e12943–e12943. 22 indexed citations
5.
Narayanan, Ramesh, Sunjoo Ahn, Muralimohan Yepuru, et al.. (2014). Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling. PLoS ONE. 9(7). e103202–e103202. 47 indexed citations
6.
Yu, Evan Y., Robert H. Getzenberg, Christopher C. Coss, et al.. (2014). Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer. European Urology. 67(2). 334–341. 16 indexed citations
7.
Yepuru, Muralimohan, Zhongzhi Wu, Anand Kulkarni, et al.. (2013). Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth. Clinical Cancer Research. 19(20). 5613–5625. 102 indexed citations
8.
Steiner, Mitchell S. & Sharan Raghow. (2003). Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World Journal of Urology. 21(1). 31–36. 58 indexed citations
9.
Jinno, Hiromitsu, Mitchell S. Steiner, Kathryn Nason-Burchenal, Michael P. Osborne, & Nitin Telang. (2002). Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells. International Journal of Oncology. 21(1). 127–34. 10 indexed citations
10.
Wang, Chiang, et al.. (2002). Immunohistological detection of BRAF25 in human prostate tumor and cancer specimens. Biochemical and Biophysical Research Communications. 295(1). 136–141. 4 indexed citations
11.
Steiner, Mitchell S., et al.. (2001). Selective estrogen receptor modulators for the chemoprevention of prostate cancer. Urology. 57(4). 68–72. 36 indexed citations
12.
Gingrich, Jeffrey R., et al.. (2001). Gene therapy for prostate cancer. Current Oncology Reports. 3(5). 438–447. 4 indexed citations
13.
Zhang, Xiongwen, et al.. (2001). Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3. Oncogene. 20(42). 5982–5990. 32 indexed citations
14.
Raghow, Sharan, et al.. (2000). Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.. PubMed. 60(15). 4093–7. 50 indexed citations
15.
Lü, Yi & Mitchell S. Steiner. (2000). Transcriptionally regulated adenoviruses for prostate-specific gene therapy. World Journal of Urology. 18(2). 93–101. 14 indexed citations
16.
Keller, F., et al.. (1998). The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous catheters. The Journal of Pediatrics. 132(1). 165–167. 5 indexed citations
17.
Goldman, Howard B., et al.. (1998). Effect of prostate biopsy on the results of the PSA RT-PCR test. Urology. 52(6). 1073–1078. 4 indexed citations
18.
Wall, Nancy A., et al.. (1995). Bone morphogenetic protein-6 expression in normal and malignant prostate. World Journal of Urology. 13(6). 337–43. 56 indexed citations
19.
Steiner, Mitchell S., et al.. (1995). Prostate cancer cells lose their sensitivity to TGFβI growth inhibition with tumor progression. Urologic Oncology Seminars and Original Investigations. 1(6). 252–262. 12 indexed citations
20.
Steiner, Mitchell S., et al.. (1993). Extragonadal germ cell tumor originating in iliac fossa. Urology. 41(6). 575–578. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Brantley Thrasher Breakdown of academic impact, for papers by Ronald A. Morton Breakdown of academic impact, for papers by Masaru Murai Breakdown of academic impact, for papers by E. David Crawford Breakdown of academic impact, for papers by Armen Aprikian Breakdown of academic impact, for papers by Satoru Kawakami Breakdown of academic impact, for papers by Stephen C. Jacobs Breakdown of academic impact, for papers by J. Edson Pontes Breakdown of academic impact, for papers by Toshiyuki Kamoto Breakdown of academic impact, for papers by Gero Kramer
Rankless by CCL
2026